XORTX Therapeutics, Inc. (XRTX)
3.06
+0.29
(+10.47%)
USD |
NASDAQ |
Apr 24, 16:00
2.97
-0.09
(-2.94%)
After-Hours: 19:00
XORTX Therapeutics EPS Diluted (Quarterly) : -0.45 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Oncolytics Biotech, Inc. | -0.0139 |
| Aurinia Pharmaceuticals, Inc. | 1.526 |
| Edesa Biotech, Inc. | -0.2819 |
| Lexaria Bioscience Corp. | -0.0593 |
| Xenon Pharmaceuticals, Inc. | -1.314 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.5905M |
| Total Expenses (Quarterly) | 0.5905M |
| Enterprise Value | 3.030M |
| Earnings Yield | -98.06% |
| Normalized Earnings Yield | -113.47 |